India’s race for the CDMO crown
For years, China+1 has been the big story in India's CDMO opportunity. Now, it…
Interviews
Why Rashida Najmi believes in running quality on trust, not vigilance
In your article for Express Pharma in April 2019, you mentioned that quality needs to be part of culture, beyond compliance.…
The next injectable pharma race will be won on reliability
The injectable pharma landscape is becoming increasingly interconnected, with pharma companies, CDMOs, device manufacturers and…
How Pivot Path is in a sweet spot to address pharma’s pressure points
Pivot Path emerged from Strides Pharma's internal GCC. Are other pharma companies also following the same playbook? And if so,…
